Marignier, Romain et al "Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder." Neurology - Neuroimmunology Neuroinflammation 8.3 (2021): e978. Web. 18 Oct. 2021.